These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 11359382

  • 1. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin.
    Touw CR, Hakkaart-Van Roijen L, Verboom P, Paul C, Rutten FF, Finlay AY.
    Br J Dermatol; 2001 May; 144(5):967-72. PubMed ID: 11359382
    [Abstract] [Full Text] [Related]

  • 2. Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral).
    Salek MS, Finlay AY, Lewis JJ, Sumner MI.
    Qual Life Res; 2004 Feb; 13(1):91-5. PubMed ID: 15058791
    [Abstract] [Full Text] [Related]

  • 3. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
    Revicki DA, Willian MK, Menter A, Saurat JH, Harnam N, Kaul M.
    Dermatology; 2008 Feb; 216(3):260-70. PubMed ID: 18187944
    [Abstract] [Full Text] [Related]

  • 4. The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis patients.
    Abrouk M, Nakamura M, Zhu TH, Farahnik B, Koo J, Bhutani T.
    J Dermatolog Treat; 2017 Sep; 28(6):488-491. PubMed ID: 28042711
    [Abstract] [Full Text] [Related]

  • 5. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
    Chaptini C, Quinn S, Marshman G.
    Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
    [Abstract] [Full Text] [Related]

  • 6. Psoriasis affects patient's quality of life more seriously in female than in male in Japan.
    Mabuchi T, Yamaoka H, Kojima T, Ikoma N, Akasaka E, Ozawa A.
    Tokai J Exp Clin Med; 2012 Sep 20; 37(3):84-8. PubMed ID: 23032250
    [Abstract] [Full Text] [Related]

  • 7. Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study.
    Imafuku S, Kanai Y, Murotani K, Nomura T, Ito K, Ohata C, Yamazaki F, Miyagi T, Takahashi H, Okubo Y, Saeki H, Honma M, Tada Y, Mabuchi T, Higashiyama M, Kobayashi S, Hashimoto Y, Seishima M, Kakuma T.
    J Dermatol Sci; 2021 Mar 20; 101(3):185-193. PubMed ID: 33495058
    [Abstract] [Full Text] [Related]

  • 8. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
    Spuls PI, Hooft L.
    Br J Dermatol; 2012 Oct 20; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low-dose cyclosporin improves the health-related quality of life in Japanese psoriasis patients dissatisfied with topical corticosteroid monotherapy.
    Hashimoto T, Kawakami T, Tsuruta D, Hamada T, Natsuaki Y, Fukuda S, Koga H, Sogame R, Ohyama B, Ono F, Karashima T, Nakama T, Dainichi T, Ishii N, Yasumoto S.
    Australas J Dermatol; 2012 Aug 20; 53(3):202-6. PubMed ID: 22881466
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of efalizumab on psoriasis-specific patient-reported outcomes. Results from three randomized, placebo-controlled clinical trials of moderate to severe plaque psoriasis.
    Menter A, Kosinski M, Bresnahan BW, Papp KA, Ware JE.
    J Drugs Dermatol; 2004 Aug 20; 3(1):27-38. PubMed ID: 14964744
    [Abstract] [Full Text] [Related]

  • 14. Low-dose, short-term ciclosporin (Neoral®) therapy is effective in improving patients' quality of life as assessed by Skindex-16 and GHQ-28 in mild to severe psoriasis patients.
    Okubo Y, Natsume S, Usui K, Amaya M, Tsuboi R.
    J Dermatol; 2011 May 20; 38(5):465-72. PubMed ID: 21352289
    [Abstract] [Full Text] [Related]

  • 15. Comparison of three methods for measuring psoriasis severity in clinical studies (Part 2 of 2): use of quality of life to assess construct validity of the Lattice System Physician's Global Assessment, Psoriasis Area and Severity Index and Static Physician's Global Assessment.
    Simpson MJ, Chow C, Morgenstern H, Luger TA, Ellis CN.
    J Eur Acad Dermatol Venereol; 2015 Jul 20; 29(7):1415-20. PubMed ID: 25917214
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group.
    Ho VC, Griffiths CE, Albrecht G, Vanaclocha F, León-Dorantes G, Atakan N, Reitamo S, Ohannesson A, Mørk NJ, Clarke P, Pfister P, Paul C.
    Br J Dermatol; 1999 Aug 20; 141(2):283-91. PubMed ID: 10468801
    [Abstract] [Full Text] [Related]

  • 18. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies.
    Mattei PL, Corey KC, Kimball AB.
    J Eur Acad Dermatol Venereol; 2014 Mar 20; 28(3):333-7. PubMed ID: 23425140
    [Abstract] [Full Text] [Related]

  • 19. Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial.
    Zhu B, Edson-Heredia E, Guo J, Maeda-Chubachi T, Shen W, Kimball AB.
    Br J Dermatol; 2014 Nov 20; 171(5):1215-9. PubMed ID: 24749812
    [Abstract] [Full Text] [Related]

  • 20. The Impact of Changes in Psoriasis Area and Severity Index by Body Region on Quality of Life in Patients with Psoriasis.
    Sojević Timotijević Z, Majcan P, Trajković G, Relić M, Novaković T, Mirković M, Djurić S, Nikolić S, Lazić B, Janković S.
    Acta Dermatovenerol Croat; 2017 Oct 20; 25(3):215-222. PubMed ID: 29252174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.